市場調査レポート

商品コード

非経口栄養の市場規模、シェア、動向分析レポート：ステージタイプ別、栄養素タイプ別、適応症別、販売チャネル別、地域別、セグメント予測、2023年～2030年

Parenteral Nutrition Market Size, Share & Trends Analysis Report By Stage Type (Adults, Pediatrics), By Nutrient Type, By Indication, By Sales Channel, By Region, And Segment Forecasts, 2023 - 2030

出版日: 2023年07月17日 | 発行: Grand View Research

| ページ情報: 英文 180 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

Unprintable PDF (Single User License)

USD 5,950 926,772円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。PDFの印刷もできません。

Printable PDF (5-User License)

USD 6,950 1,082,532円

レポートPDFを同一企業内の同一部署における5名様までの方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

Printable PDF (Enterprise License)

USD 8,950 1,394,052円

レポートPDFの購入企業、およびその子会社、関連会社の方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=155.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

非経口栄養市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の非経口栄養の市場規模は2030年までに107億米ドルに達し、予測期間中のCAGRは6.0％を記録すると予測されています。

がん、糖尿病、その他の神経疾患などの慢性疾患の増加、重症患者における必須栄養欠乏症の急増、病院関連の栄養不良に関する意識の高まりは、非経口栄養の採用を増加させるいくつかの主な要因です。非経口薬の投与は、即効性と低用量デリバリーという利点を提供し、食事の不均衡によるさまざまな副作用を防ぐため、市場の成長を促進します。

しかし、投与中の感染リスクが高いことや、患者の間で経腸栄養への嗜好が高まっていることが、市場の成長を抑制する主な要因となっています。人口の増加に伴い、家庭や国家の医療コストと食費は増大しています。したがって、出生率の上昇は栄養水準に影響を与えると予想され、それによって市場の促進要因として作用します。出生率には、出生1件当たりの水、食料、投薬の必要量など、環境面だけでなく資源面での圧力も含まれるため、絶対的出生率（粗出生率）よりも実現出生率の方が重要な役割を果たします。実現出生率は過去10年間で増加しており、予測期間中も成長を維持すると予想されます。

2020年、全米保健統計センター（NCHS）が報告する出生率は、人口1,000人当たり11.99人です。さらに、低体重児の割合は8.0%であり、PN製品に対する需要を世界的に押し上げています。さらに、60歳以上の高齢者が多く、免疫力が低く、神経疾患、心臓疾患、がん、脊椎損傷などの発症が多いことが、予測期間中、非経口脂質エマルジョン市場にとってインパクトのある促進要因となっています。このような人々は最新の外科治療を利用することが予想され、それによって寿命が延び、脂質乳剤のようなPN製品を含む集中治療と術後治療の必要性が高まると予想されます。

非経口栄養市場レポートハイライト

市場で事業を展開する主要企業は、主に患者の安全性を高めることに注力しています。各社はまた、バーコード支援投薬などの技術を取り入れることで、非経口栄養の配合を補完するPN製品の進歩にも注力しています。
改善された脂質製剤やタンパク質製剤を患者に提供する能力は、各社が競合他社から自社製品を差別化するために活用する重要なパラメータの1つです。
また、感染率の高さ、劣悪な水質と衛生設備、意識の欠如は、新興国での栄養不良の発生率を増加させる一般的な要因であり、これがPN源に対する大きな需要を生み出し、市場の成長を助長しています。
2022年には、単回投与アミノ酸溶液の栄養素タイプが市場を独占しましたが、これは副作用の少ないアミノ酸溶液が新たに登場したためです。
2022年には、この年齢層におけるアルツハイマー病、サルコペニア、がん、糖尿病などのさまざまな慢性疾患の有病率の上昇に起因する非経口栄養製品の採用増加により、成人セグメントが最大のシェアを占めました。
2022年には、クローン病、嚢胞性線維症、膵炎、その他のがん関連治療、その他の健康疾患の有病率の増加により、その他の適応症セグメントが市場を独占しました。
2022年には、民間・公的医療機関の数の多さと慢性疾患患者の増加により、機関の販売チャネルが市場を独占しました。
北米は、慢性疾患と栄養不良の罹患率の上昇に加え、米国FDAの承認が増加していることから、2022年の世界市場を独占しました。

市場系統の見通し
- 親市場の見通し
- 付随市場の見通し
ユーザー視点の分析
- 消費者行動分析
- 市場影響力分析
規制の枠組み
- 償還の枠組み
- 規格とコンプライアンス
市場力学
- 市場促進要因分析
- 市場抑制要因分析
- 業界の課題
非経口栄養市場分析ツール
- 業界分析- ポーター
- PESTEL分析
COVID-19が非経口栄養市場に与える影響

第4章非経口栄養市場：栄養素タイプの推定・動向分析

セグメントダッシュボード
非経口栄養市場：栄養素タイプの変動分析、2022年および2030年
- 炭水化物
- 非経口脂質エマルジョン
- 単回投与アミノ酸溶液
- 微量元素
- ビタミン・ミネラル

第5章非経口栄養市場：ステージタイプの推定・動向分析

セグメントダッシュボード
非経口栄養市場：ステージタイプの変動分析、2022年および2030年
- 成人
- 小児

第6章非経口栄養市場：適応症の推定と推定・動向分析

セグメントダッシュボード
非経口栄養市場：適応症の変動分析、2022年および2030年
- アルツハイマー病
- 栄養欠乏症
- がん治療
- 糖尿病
- 慢性腎臓病
- 希少疾患
- 嚥下障害
- 疼痛管理
- 吸収不良/消化器疾患/下痢
- その他

第7章非経口栄養市場：販売チャネルの推定・動向分析

セグメントダッシュボード
非経口栄養市場：販売チャネルの変動分析、2022年および2030年
- オンライン販売
- 小売販売
- 機関販売

第8章非経口栄養市場：地域の推定・動向分析

定義と範囲
地域の市場シェア分析、2022年および2030年
地域の市場ダッシュボード
地域の市場スナップショット
市場規模、予測、収益および動向分析、2022年から2030年まで
- 北米
- 欧州
- アジア太平洋地域
- ラテンアメリカ
- 中東・アフリカ

第9章競合情勢

企業の分類
主要企業の市況分析
主要企業の市場シェア分析
主要な市場参入企業による最近の開発と影響分析
企業プロファイル
- Braun Melsungen AG
- Fresenius kabi AG
- Allergan
- Grifols SA
- Pfizer Inc.
- Otsuka Pharmaceutical Factory, Inc
- Baxter
- Aculife
- Sichuan Kelun Pharmaceutical Co., Ltd
- Vifor Pharma

図表

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 4 North America Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 5 North America Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 6 North America Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 7 U.S. Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 8 U.S. Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 9 U.S. Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 10 U.S. Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 11 Canada Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 12 Canada Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 13 Canada Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 14 Canada Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 15 Europe Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 16 Europe Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 17 Europe Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 18 Europe Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 19 UK Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 20 UK Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 21 UK Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 22 UK Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 23 Germany Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 24 Germany Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 25 Germany Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 26 Germany Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 27 France Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 28 France Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 29 France Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 30 France Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 31 Italy Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 32 Italy Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 33 Italy Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 34 Italy Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 35 Spain Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 36 Spain Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 37 Spain Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 38 Spain Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 39 Sweden Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 40 Sweden Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 41 Sweden Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 42 Sweden Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 43 Denmark Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 44 Denmark Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 45 Denmark Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 46 Denmark Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 47 Norway Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 48 Norway Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 49 Norway Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 50 Norway Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 51 Asia Pacific Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 52 Asia Pacific Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 53 Asia Pacific Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 54 Asia Pacific Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 55 Japan Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 56 Japan Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 57 Japan Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 58 Japan Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 59 China Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 60 China Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 61 China Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 62 China Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 63 India Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 64 India Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 65 India Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 66 India Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 67 Australia Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 68 Australia Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 69 Australia Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 70 Australia Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 71 South Korea Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 72 South Korea Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 73 South Korea Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 74 South Korea Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 75 Thailand Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 76 Thailand Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 77 Thailand Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 78 Thailand Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 79 Latin America Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 80 Latin America Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 81 Latin America Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 82 Latin America. Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 83 Brazil Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 84 Brazil Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 85 Brazil Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 86 Brazil Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 87 Mexico Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 88 Mexico Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 89 Mexico Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 90 Mexico. Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 91 Argentina Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 92 Argentina Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 93 Argentina Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 94 Argentina Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 95 MEA Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 96 MEA Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 97 MEA Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 98 MEA Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 99 South Africa Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 100 South Africa Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 101 South Africa Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 102 South Africa Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 103 Saudi Arabia Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 104 Saudi Arabia Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 105 Saudi Arabia Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 106 Saudi Arabia Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 107 UAE Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 108 UAE Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 109 UAE Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 110 UAE Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 111 Kuwait Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 112 Kuwait Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 113 Kuwait Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 114 Kuwait Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity Flow Analysis
Fig. 9 Volume Price Analysis
Fig. 10 Parenteral nutrition market snapshot (2022)
Fig. 11 Parenteral nutrition market segmentation
Fig. 12 Parenteral nutrition market: Strategy framework
Fig. 13 Market trends and outlook
Fig. 14 Parent market outlook
Fig. 15 Related/ancillary market outlook
Fig. 16 Penetration & growth prospect mapping
Fig. 17 Market driver relevance analysis (Current & future impact)
Fig. 18 Market restraint relevance analysis (Current & future impact)
Fig. 19 Parenteral nutrition market, nutrient type outlook: key takeaways (USD Million)
Fig. 20 Parenteral nutrition market: nutrient type movement analysis, 2022 & 2030 (USD Million)
Fig. 21 Carbohydrates market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Single dose amino acid solution market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Trace elements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Vitamins & Minerals market estimates and forecasts, 2018 - 2030 (USD Million
Fig. 26 Parenteral nutrition market, stage type outlook: key takeaways (USD Million)
Fig. 27 Parenteral nutrition market: stage type movement analysis, 2022 & 2030 (USD Million)
Fig. 28 Adult market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Pediatrics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Parenteral nutrition market, Indication outlook: key takeaways (USD Million)
Fig. 31 Parenteral nutrition market: Indication movement analysis, 2022 & 2030 (USD Million)
Fig. 32 Alzheimer's market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Nutrition Deficiency market estimates and forecasts, 2018 - 2030 (USD Million
Fig. 34 Cancer Care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Diabetes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Chronic kidney disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Orphan disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Dysphagia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Pain management market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Malabsorption/GI Disorder/Diarrhea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Parenteral nutrition market, regional marketplace: Key takeaways (USD Million)
Fig. 43 Parenteral nutrition market: regional movement analysis, 2022 & 2030 (USD Million)
Fig. 44 North America Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 U.S. Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Canada Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Europe Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Germany Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 UK Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 France Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Spain Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Italy Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Sweden Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Denmark Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Norway Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Asia Pacific Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Japan Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 China Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 India Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Australia Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 South Korea Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Thailand Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Latin America Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Brazil Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Mexico Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Argentina Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 MEA Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 South Africa Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Saudi Arabia Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 UAE Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Kuwait Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)

Product Code: 978-1-68038-867-1

Parenteral Nutrition Market Growth & Trends

The global parenteral nutrition market size is expected to reach USD 10.7 billion by 2030, registering a CAGR of 6.0% over the forecast period, according to a new report by Grand View Research, Inc. Growing incidences of chronic diseases, such as cancer, diabetes, and other neurological conditions; surge in essential nutrition deficiency among critically ill patients; and growing awareness pertaining to hospital-related malnutrition are few key factors increasing the adoption of parenteral nutrition. Parenteral drug administration provides the benefit of fast action and lower dose delivery, which prevent various adverse effects because of dietary imbalances, thereby promoting market growth.

However, the high risk of infection during administration and the growing preference for enteral nutrition among patients are major factors restricting the market growth. With the increasing population, healthcare costs and food expenditures for a household and the nation are growing. Hence, a higher birth rate is expected to impact nutrition levels, thereby acting as a driver for the market. Realized natality plays a more prominent role than absolute natality (crude birth rate), as it includes environmental as well as resource pressures, such as water, food, and medication requirements per birth. Realized natality has been growing in the last decade and is anticipated to maintain growth over the forecast period.

In 2020, the natality rate reported by the National Center for Health Statistics (NCHS) is 11.99 births per 1,000 population. Furthermore, the percentage of lower-weight infants was 8.0%, thereby boosting the demand for PN products worldwide. Furthermore, the presence of a large population base, aged above 60 years, suffering from low immunity levels, and prone to incidence of neurological diseases, cardiac problems, cancers, and spinal injuries, is a high-impact rendering driver for the parenteral lipid emulsions market over the forecast period. This population is expected to avail the latest surgical treatments, which is expected to increase their life span, thereby driving the need for intensive care & postoperative treatment, inclusive of PN products, such as lipid emulsions.

Parenteral Nutrition Market Report Highlights

Key players operating in the market are mainly focused on enhancing patient safety. Companies are also focusing on advancing their PN products to complement the parenteral nutrition compounding by incorporating technologies, such as barcode-assisted medication.
The ability to provide improved lipid and protein formulations to patients is one of the key parameters that companies leverage to differentiate their products from competitors
Also, high infection rates, poor water quality & sanitation facilities, and lack of awareness are prevalent factors increasing the incidence of malnourishment in developing nations, which creates a significant demand for PN sources, thereby aiding market growth
The single-dose amino acid solution nutrient type segment dominated the market in 2022 due to the introduction of newly available amino acid solutions with minimal side effects
In 2022, the adult segment held the largest share due to increased adoption of parenteral nutrition products owing to the rising prevalence of various chronic diseases, such as Alzheimer's disease, sarcopenia, cancer, and diabetes among this age group
The others indication segment dominated the market in 2022 due to the increased prevalence of Crohn's disease, cystic fibrosis, pancreatitis, other cancer-related treatment, and other health ailments
In 2022, institutional sales channels dominated the market owing to the high number of private & public healthcare institutions and the increased patient population with chronic disease
North America dominated the global market in 2022 owing to the rising incidence of chronic conditions & malnutrition, coupled with increasing U.S. FDA approvals in the region

Chapter 1. Methodology and Scope

1.1. Research Process
1.2. Information Procurement
- 1.2.1. Purchased database
  - 1.2.1.1. GVR's internal database
- 1.2.2. Market Formulation & Validation
1.3. Research Methodology
1.4. Research Scope and Assumptions
1.5. Research Methodology
- 1.5.1. Region Market: CAGR Calculation
- 1.5.2. Region Based Segment Share Calculation
1.6. List To Data Nutrient Type

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
2.4. Parenteral Nutrition Market Snapshot

Chapter 3. Parenteral Nutrition Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary Market Outlook
3.2. User Perspective Analysis
- 3.2.1. Consumer Behavior Analysis
- 3.2.2. Market Influencer Analysis
3.3. Regulatory Framework
- 3.3.1. Reimbursement Framework
- 3.3.2. Standard & Compliance
3.4. Market Dynamics
- 3.4.1. Market Driver Analysis
- 3.4.2. Market Restraint Analysis
- 3.4.3. Industry Challenge
3.5. Parenteral Nutrition Market Analysis Tools
- 3.5.1. Industry Analysis - Porter's
  - 3.5.1.1. Bargaining power of the suppliers
  - 3.5.1.2. Bargaining power of the buyers
  - 3.5.1.3. Threats of substitution
  - 3.5.1.4. Threats from new entrants
  - 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL Analysis
  - 3.5.2.1. Political landscape
  - 3.5.2.2. Economic and Social landscape
  - 3.5.2.3. Technological landscape
3.6. Impact of COVID 19 on Parenteral Nutrition Market

Chapter 4. Parenteral Nutrition Market: Nutrient Type Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Parenteral Nutrition Market: Nutrient Type Movement Analysis, 2022 & 2030 (USD Million)
- 4.2.1. Carbohydrates
  - 4.2.1.1. Carbohydrates Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.2. Parenteral Lipid Emulsion
  - 4.2.2.1. Parenteral Lipid Emulsion Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.3. Single Dose Amino Acid Solution
  - 4.2.3.1. Single Dose Amino Acid Solution Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.4. Trace Elements
  - 4.2.4.1. Trace Elements Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.5. Vitamins & Minerals
  - 4.2.5.1. Vitamins & Minerals Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Parenteral Nutrition Market: Stage Type Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Parenteral Nutrition Market: Stage Type Movement Analysis, 2022 & 2030 (USD Million)
- 5.2.1. Adult
  - 5.2.1.1. Adult Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 5.2.2. Pediatrics
  - 5.2.2.1. Pediatrics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Parenteral Nutrition Market: Indication Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Parenteral Nutrition Market: Indication Movement Analysis, 2022 & 2030 (USD Million)
- 6.2.1. Alzheimer's
  - 6.2.1.1. Alzheimer's Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.2. Nutrition Deficiency
  - 6.2.2.1. Nutrition Deficiency Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.3. Cancer Care
  - 6.2.3.1. Cancer Care Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.4. Diabetes
  - 6.2.4.1. Diabetes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.5. Chronic Kidney Disease
  - 6.2.5.1. Chronic Kidney Disease Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.6. Orphan Disease
  - 6.2.6.1. Orphan Disease Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.7. Dysphagia
  - 6.2.7.1. Dysphagia Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.8. Pain Management
  - 6.2.8.1. Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.9. Malabsorption/GI Disorder/Diarrhea
  - 6.2.9.1. Malabsorption/GI Disorder/Diarrhea Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.10. Others
  - 6.2.10.1. Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Parenteral Nutrition Market: Sales Channel Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Parenteral Nutrition Market: Sales Channel Movement Analysis, 2022 & 2030 (USD Million)
- 7.2.1. Online Sales
  - 7.2.1.1. Online Sales Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.2.2. Retail Sales
  - 7.2.2.1. Retail Sales Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.2.3. Institutional Sales
  - 7.2.3.1. Institutional Sales Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Parenteral Nutrition Market: Regional Estimates & Trend Analysis

8.1. Definition & Scope
8.2. Regional Market Share Analysis, 2022 & 2030
8.3. Regional Market Dashboard
8.4. Regional Market Snapshot
8.5. Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
- 8.5.1. North America
  - 8.5.1.1. North America Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
  - 8.5.1.2. U.S.
  - 8.5.1.2.1. Key Country Dynamics
  - 8.5.1.2.2. Competitive Scenario
  - 8.5.1.2.3. Regulatory Framework
  - 8.5.1.2.4. Reimbursement Scenario
  - 8.5.1.2.5. U.S. Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
  - 8.5.1.3. Canada
  - 8.5.1.3.1. Key Country Dynamics
  - 8.5.1.3.2. Competitive Scenario
  - 8.5.1.3.3. Regulatory Framework
  - 8.5.1.3.4. Reimbursement Scenario
  - 8.5.1.3.5. Canada Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.2. Europe
  - 8.5.2.1. Europe Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
  - 8.5.2.2. UK
  - 8.5.2.2.1. Key Country Dynamics
  - 8.5.2.2.2. Competitive Scenario
  - 8.5.2.2.3. Regulatory Framework
  - 8.5.2.2.4. Reimbursement Scenario
  - 8.5.2.2.5. UK Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
  - 8.5.2.3. Germany
  - 8.5.2.3.1. Key Country Dynamics
  - 8.5.2.3.2. Competitive Scenario
  - 8.5.2.3.3. Regulatory Framework
  - 8.5.2.3.4. Reimbursement Scenario
  - 8.5.2.3.5. Germany Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
  - 8.5.2.4. France
  - 8.5.2.4.1. Key Country Dynamics
  - 8.5.2.4.2. Competitive Scenario
  - 8.5.2.4.3. Regulatory Framework
  - 8.5.2.4.4. Reimbursement Scenario
  - 8.5.2.4.5. France Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
  - 8.5.2.5. Italy
  - 8.5.2.5.1. Key Country Dynamics
  - 8.5.2.5.2. Competitive Scenario
  - 8.5.2.5.3. Regulatory Framework
  - 8.5.2.5.4. Reimbursement Scenario
  - 8.5.2.5.5. Italy Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
  - 8.5.2.6. Spain
  - 8.5.2.6.1. Key Country Dynamics
  - 8.5.2.6.2. Competitive Scenario
  - 8.5.2.6.3. Regulatory Framework
  - 8.5.2.6.4. Reimbursement Scenario
  - 8.5.2.6.5. Spain Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
  - 8.5.2.7. Denmark
  - 8.5.2.7.1. Key Country Dynamics
  - 8.5.2.7.2. Competitive Scenario
  - 8.5.2.7.3. Regulatory Framework
  - 8.5.2.7.4. Reimbursement Scenario
  - 8.5.2.7.5. Denmark Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
  - 8.5.2.8. Sweden
  - 8.5.2.8.1. Key Country Dynamics
  - 8.5.2.8.2. Competitive Scenario
  - 8.5.2.8.3. Regulatory Framework
  - 8.5.2.8.4. Reimbursement Scenario
  - 8.5.2.8.5. Sweden Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
  - 8.5.2.9. Norway
  - 8.5.2.9.1. Key Country Dynamics
  - 8.5.2.9.2. Competitive Scenario
  - 8.5.2.9.3. Regulatory Framework
  - 8.5.2.9.4. Reimbursement Scenario
  - 8.5.2.9.5. Norway Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.3. Asia Pacific
  - 8.5.3.1. Asia Pacific Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
  - 8.5.3.2. Japan
  - 8.5.3.2.1. Key Country Dynamics
  - 8.5.3.2.2. Competitive Scenario
  - 8.5.3.2.3. Regulatory Framework
  - 8.5.3.2.4. Reimbursement Scenario
  - 8.5.3.2.5. Japan Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
  - 8.5.3.3. India
  - 8.5.3.3.1. Key Country Dynamics
  - 8.5.3.3.2. Competitive Scenario
  - 8.5.3.3.3. Regulatory Framework
  - 8.5.3.3.4. Reimbursement Scenario
  - 8.5.3.3.5. India Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
  - 8.5.3.4. China
  - 8.5.3.4.1. Key Country Dynamics
  - 8.5.3.4.2. Competitive Scenario
  - 8.5.3.4.3. Regulatory Framework
  - 8.5.3.4.4. Reimbursement Scenario
  - 8.5.3.4.5. China Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
  - 8.5.3.5. Australia
  - 8.5.3.5.1. Key Country Dynamics
  - 8.5.3.5.2. 8. 6. 3.5Competitive Scenario
  - 8.5.3.5.3. Regulatory Framework
  - 8.5.3.5.4. Reimbursement Scenario
  - 8.5.3.5.5. Australia Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
  - 8.5.3.6. Thailand
  - 8.5.3.6.1. Key Country Dynamics
  - 8.5.3.6.2. 8. Competitive Scenario
  - 8.5.3.6.3. Regulatory Framework
  - 8.5.3.6.4. Reimbursement Scenario
  - 8.5.3.6.5. Thailand Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
  - 8.5.3.7. South Korea
  - 8.5.3.7.1. Key Country Dynamics
  - 8.5.3.7.2. 8. 6. 3.7Competitive Scenario
  - 8.5.3.7.3. Regulatory Framework
  - 8.5.3.7.4. Reimbursement Scenario
  - 8.5.3.7.5. South Korea Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.6 Latin America
  - 8.5.6.1. Latin America Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
  - 8.5.6.2. Brazil
  - 8.5.6.2.1. Key Country Dynamics
  - 8.5.6.2.2. Competitive Scenario
  - 8.5.6.2.3. Regulatory Framework
  - 8.5.6.2.4. Reimbursement Scenario
  - 8.5.6.2.5. Brazil Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
  - 8.5.6.3. Mexico
  - 8.5.6.3.1. Key Country Dynamics
  - 8.5.6.3.2. Competitive Scenario
  - 8.5.6.3.3. Regulatory Framework
  - 8.5.6.3.4. Reimbursement Scenario
  - 8.5.6.3.5. 6. 4.3.5 Mexico Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
  - 8.5.6.4. Argentina
  - 8.5.6.4.1. Key Country Dynamics
  - 8.5.6.4.2. Competitive Scenario
  - 8.5.6.4.3. Regulatory Framework
  - 8.5.6.4.4. Reimbursement Scenario
  - 8.5.6.4.5. Argentina Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.7. MEA
  - 8.5.7.1. MEA Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
  - 8.5.7.2. South Africa
  - 8.5.7.2.1. Key Country Dynamics
  - 8.5.7.2.2. Competitive Scenario
  - 8.5.7.2.3. Regulatory Framework
  - 8.5.7.2.4. Reimbursement Scenario
  - 8.5.7.2.5. South Africa Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
  - 8.5.7.3. Saudi Arabia
  - 8.5.7.3.1. Key Country Dynamics
  - 8.5.7.3.2. Competitive Scenario
  - 8.5.7.3.3. Regulatory Framework
  - 8.5.7.3.4. Reimbursement Scenario
  - 8.5.7.3.5. Saudi Arabia Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
  - 8.5.7.4. UAE
  - 8.5.7.4.1. Key Country Dynamics
  - 8.5.7.4.2. Competitive Scenario
  - 8.5.7.4.3. Regulatory Framework
  - 8.5.7.4.4. Reimbursement Scenario
  - 8.5.7.4.5. UAE Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
  - 8.5.7.5. Kuwait
  - 8.5.7.5.1. Key Country Dynamics
  - 8.5.7.5.2. Competitive Scenario
  - 8.5.7.5.3. Regulatory Framework
  - 8.5.7.5.4. Reimbursement Scenario
  - 8.5.7.5.5. Kuwait Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Company Categorization
9.2. Key Company Market Position Analysis
9.3. Key Company Market Share Analysis
9.4. Recent Development and Impact Analysis, by key Market Participants
9.5. Company Profiles
- 9.5.1. Braun Melsungen AG
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Financial Performance
  - 9.5.1.3. Product Benchmarking
  - 9.5.1.4. Strategic initiatives
- 9.5.2. Fresenius kabi AG
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Financial Performance
  - 9.5.2.3. Product Benchmarking
  - 9.5.2.4. Strategic initiatives
- 9.5.3. Allergan
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Financial Performance
  - 9.5.3.3. Product Benchmarking
  - 9.5.3.4. Strategic initiatives
- 9.5.4. Grifols S.A.
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Financial Performance
  - 9.5.4.3. Product Benchmarking
  - 9.5.4.4. Strategic initiatives
- 9.5.5. Pfizer Inc.
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Financial Performance
  - 9.5.5.3. Product Benchmarking
  - 9.5.5.4. Strategic initiatives
- 9.5.6. Otsuka Pharmaceutical Factory, Inc
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Financial Performance
  - 9.5.6.3. Product Benchmarking
  - 9.5.6.4. Strategic initiatives
- 9.5.7. Baxter
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Financial Performance
  - 9.5.7.3. Product Benchmarking
  - 9.5.7.4. Strategic initiatives
- 9.5.8. Aculife
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Financial Performance
  - 9.5.8.3. Product Benchmarking
  - 9.5.8.4. Strategic initiatives
- 9.5.9. Sichuan Kelun Pharmaceutical Co., Ltd
  - 9.5.9.1. Company Overview
  - 9.5.9.2. Financial Performance
  - 9.5.9.3. Product Benchmarking
  - 9.5.9.4. Strategic initiatives
- 9.5.10. Vifor Pharma
  - 9.5.10.1. Company Overview
  - 9.5.10.2. Financial Performance
  - 9.5.10.3. Product Benchmarking
  - 9.5.10.4. Strategic initiatives

非経口栄養の市場規模、シェア、動向分析レポート：ステージタイプ別、栄養素タイプ別、適応症別、販売チャネル別、地域別、セグメント予測、2023年～2030年

Parenteral Nutrition Market Size, Share & Trends Analysis Report By Stage Type (Adults, Pediatrics), By Nutrient Type, By Indication, By Sales Channel, By Region, And Segment Forecasts, 2023 - 2030

非経口栄養市場の成長と動向

非経口栄養市場レポートハイライト

目次

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章非経口栄養市場の変数、動向、および範囲

第4章非経口栄養市場：栄養素タイプの推定・動向分析

第5章非経口栄養市場：ステージタイプの推定・動向分析

第6章非経口栄養市場：適応症の推定と推定・動向分析

第7章非経口栄養市場：販売チャネルの推定・動向分析

第8章非経口栄養市場：地域の推定・動向分析

第9章競合情勢

List of Tables

List of Figures

Parenteral Nutrition Market Growth & Trends

Parenteral Nutrition Market Report Highlights

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Parenteral Nutrition Market Variables, Trends, & Scope

Chapter 4. Parenteral Nutrition Market: Nutrient Type Estimates & Trend Analysis

Chapter 5. Parenteral Nutrition Market: Stage Type Estimates & Trend Analysis

Chapter 6. Parenteral Nutrition Market: Indication Estimates & Trend Analysis

Chapter 7. Parenteral Nutrition Market: Sales Channel Estimates & Trend Analysis

Chapter 8. Parenteral Nutrition Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

非経口栄養の市場規模、シェア、動向分析レポート：ステージタイプ別、栄養素タイプ別、適応症別、販売チャネル別、地域別、セグメント予測、2023年～2030年

Parenteral Nutrition Market Size, Share & Trends Analysis Report By Stage Type (Adults, Pediatrics), By Nutrient Type, By Indication, By Sales Channel, By Region, And Segment Forecasts, 2023 - 2030

非経口栄養市場の成長と動向

非経口栄養市場レポートハイライト

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 非経口栄養市場の変数、動向、および範囲

第4章 非経口栄養市場：栄養素タイプの推定・動向分析

第5章 非経口栄養市場：ステージタイプの推定・動向分析

第6章 非経口栄養市場：適応症の推定と推定・動向分析

第7章 非経口栄養市場：販売チャネルの推定・動向分析

第8章 非経口栄養市場：地域の推定・動向分析

第9章 競合情勢

List of Tables

List of Figures

Parenteral Nutrition Market Growth & Trends

Parenteral Nutrition Market Report Highlights

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Parenteral Nutrition Market Variables, Trends, & Scope

Chapter 4. Parenteral Nutrition Market: Nutrient Type Estimates & Trend Analysis

Chapter 5. Parenteral Nutrition Market: Stage Type Estimates & Trend Analysis

Chapter 6. Parenteral Nutrition Market: Indication Estimates & Trend Analysis

Chapter 7. Parenteral Nutrition Market: Sales Channel Estimates & Trend Analysis

Chapter 8. Parenteral Nutrition Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章非経口栄養市場の変数、動向、および範囲

第4章非経口栄養市場：栄養素タイプの推定・動向分析

第5章非経口栄養市場：ステージタイプの推定・動向分析

第6章非経口栄養市場：適応症の推定と推定・動向分析

第7章非経口栄養市場：販売チャネルの推定・動向分析

第8章非経口栄養市場：地域の推定・動向分析

第9章競合情勢